Neoleukin Therapeutics Inc Annual Shareholders Meeting Transcript
Welcome to the 2021 Annual Meeting of Stockholders of Neoleukin Therapeutics, Inc. (Operator Instructions)
I would now like to turn the call over to Bob Ho, Chief Financial Officer of Neoleukin Therapeutics.
Good afternoon. I'm Bob Ho, Chief Financial Officer of Neoleukin Therapeutics, Inc., which we will refer to as Neoleukin in what follows.
Welcome to our 2021 annual meeting of the stockholders. I would like to introduce Dr. Jonathan Drachman, Chief Executive Officer, President and member of the Board of Directors, who will call the meeting to order.
Good afternoon. My name is Jonathan Drachman. I am the Chief Executive Officer, President and a director of Neoleukin. I now call the meeting to order.
With us here today are the following members of our Board of Directors: Martin Babler, Erin Lavelle, Sarah Noonberg, Todd Simpson, Rusty Williams, and myself,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |